08/22/2019
In this podcast, Matthew Robbins, MD, overviews the treatments for migraine that are currently available, assesses the risks and benefits of using each treatment in clinical practice, and explains how to use some of these treatments in special populations.
Matthew Robbins, MD, is a neurologist and headache specialist at Weill Cornell Medicine and New York-Presbyterian Hospital in New York City. He is also the neurology residency program director at Weill Cornell Medical College and a board member for the American Headache Society.
Additional Resources:
- American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1-18. https://doi.org/10.1111/head.13456.
- Robbins M. Practical clinical issues regarding new acute and preventive headache therapies. Talk presented at: 61st Annual Scientific Meeting of the American Headache Society; July 11-14, 2019; Philadelphia, PA. https://americanheadachesociety.org/events/61st-annual-scientific-meeting/#scheduleprogram-agenda.
